Efficacy and safety treating the recurrent hepatitis C post-liver transplantation with Simeprevir and sofosbuvir: The Spanish experience(SETH)

被引:0
|
作者
Sanchez-Antolin, Gloria [1 ,20 ]
Testillano, Milagros [4 ]
Prieto, Martin [2 ]
Fernandez, Inmaculada [5 ]
Xiol, Xavier [8 ]
Londono, Maria-Carlota [9 ]
Castells, Lluis [7 ]
Manuel Pascasio, Juan [3 ]
Gonzalez Dieguez, Maria Luisa [10 ]
Otero, Alejandra [6 ]
Salcedo, Magdalena [11 ]
Narvaez, Isidoro [12 ]
Pons, Jose A. [13 ]
Ignacio Herrero, J. [14 ]
Pascual, Sonia [15 ]
Luis Montero, Jose [21 ]
Arencibia, Ana [16 ]
Lorente, Sara [17 ]
Molina, Esther [18 ]
Ramon Fernandez, Jose [4 ]
Cuervas-Mons, Valentin [19 ]
机构
[1] Univ Valladolid, Valladolid, Spain
[2] Hosp La Fe, Hepatol Unit, Valencia, Spain
[3] Hosp Univ Virgen del Rocio, Ciberehd, IBIS, Gastroenterol Serv, Seville, Spain
[4] Hosp Cruces, Hepatol Unit, Bilbao, Spain
[5] Hosp Univ 12 Octubre, Hepatol Unit, Madrid, Spain
[6] Hosp Univ A Coruna, Liver Transplant Unit, La Coruna, Spain
[7] Hosp Univ Vall de Hebron, Hepatol Serv, Barcelona, Spain
[8] Bellvitge Hosp, Hepatol Unit, Barcelona, Spain
[9] Hosp Clin Barcelona, Ciberehd, IDIBAPS, Hepatol Serv, Barcelona, Spain
[10] Hosp Cent Asturias, Hepatol Unit, Oviedo, Spain
[11] Hosp Gregorio Maranon, Hepatol Unit, Madrid, Spain
[12] Hosp Infanta Cristina, Hepatol Unit, Badajoz, Spain
[13] Hosp La Arreixaca, Hepatol Unit, Murcia, Spain
[14] Univ Navarra Clin, Hepatol Serv, Pamplona, Spain
[15] Hosp Gen Alicante, Hepatol Unit, Alicante, Spain
[16] Hosp Univ La Candelaria, Hepatol Unit, Tenerife, Spain
[17] Hosp Univ Lozano Blesa, Hepatol Unit, Zaragoza, Spain
[18] Hosp Univ Santiago, Hepatol Unit, Santiago De Compostela, Spain
[19] Hosp Univ Puerta de Hierro, Liver Trasplant Unit, Internal Med, Madrid, Spain
[20] Hosp Univ Rio Hortega, Hepatol Unit, Valladolid, Spain
[21] Hosp Univ Reina Sofia, CIBERehd, IMIBIC, Hepatol Unit, Cordoba, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
213
引用
收藏
页码:113A / 113A
页数:1
相关论文
共 50 条
  • [31] Single Center Experience with Simeprevir/Sofosbuvir Combination Therapy for Recurrent Hepatitis C Virus Infection in Liver Transplant Recipients
    Crittenden, Neil
    Davis, Eric G.
    Marsano, Luis S.
    McClain, Craig J.
    Barve, Ashutosh
    Goshko, Barbra A.
    Tatum, Robert R.
    Hughes, Michael G.
    Jones, Christopher M.
    Marvin, Michael R.
    Cave, Matthew C.
    [J]. HEPATOLOGY, 2014, 60 : 700A - 700A
  • [32] Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantation
    Oya, Yuki
    Sugawara, Yasuhiko
    Watanabe, Takehisa
    Yoshimaru, Yoko
    Honda, Masaki
    Hashimoto, Shintaro
    Yoshii, Daiki
    Isono, Kaori
    Hayashida, Shintaro
    Yamamoto, Hidekazu
    Tanaka, Motohiko
    Sasaki, Yutaka
    Inomata, Yukihiro
    [J]. BIOSCIENCE TRENDS, 2016, 10 (06) : 496 - 499
  • [33] Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation
    Berenguer, Marina
    Charco, Ramon
    Manuel Pascasio, Juan
    Ignacio Herrero, Jose
    [J]. LIVER INTERNATIONAL, 2012, 32 (05) : 712 - 731
  • [34] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [35] Efficacy and safety of sofosbuvir plus simeprevir therapy in Egyptian patients with chronic hepatitis C: a real-world experience
    El-Khayat, Hisham R.
    Fouad, Yasser M.
    Maher, Mohsen
    El-Amin, Hussain
    Muhammed, Hala
    [J]. GUT, 2017, 66 (11) : 2008 - +
  • [36] The Hepatitis Aggressiveness Score (HAS) A Novel Classification System for Post-Liver Transplantation Recurrent Hepatitis C
    Moreira, Roger K.
    Salomao, Marcela
    Verna, Elizabeth C.
    Brown, Robert S., Jr.
    Lefkowitch, Jay H.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (01) : 104 - 113
  • [37] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [38] Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
    Fontana, Robert J.
    Brown, Robert S., Jr.
    Moreno-Zamora, Ana
    Prieto, Martin
    Joshi, Shobha
    Londono, Maria-Carlota
    Herzer, Kerstin
    Chacko, Kristina R.
    Stauber, Rudolf E.
    Knop, Viola
    Jafri, Syed-Mohammed
    Castells, Lluis
    Ferenci, Peter
    Torti, Carlo
    Durand, Christine M.
    Loiacono, Laura
    Lionetti, Raffaella
    Bahirwani, Ranjeeta
    Weiland, Ola
    Mubarak, Abdullah
    ElSharkawy, Ahmed M.
    Stadler, Bernhard
    Montalbano, Marzia
    Berg, Christoph
    Pellicelli, Adriano M.
    Stenmark, Stephan
    Vekeman, Francis
    Ionescu-Ittu, Raluca
    Emond, Bruno
    Reddy, K. Rajender
    [J]. LIVER TRANSPLANTATION, 2016, 22 (04) : 446 - 458
  • [39] Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant
    Punzalan, Carmi Santos
    Barry, Curtis
    Zacharias, Isabel
    Rodrigues, Julie
    Mehta, Savant
    Bozorgzadeh, Adel
    Barnard, Graham F.
    [J]. CLINICAL TRANSPLANTATION, 2015, 29 (12) : 1105 - 1111
  • [40] Recurrent hepatitis C post-liver transplant: the lessons learned
    Martin, Paul
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : 710 - 712